Pompe Alliance Hosts Town Hall on Budget Impacts for Rare Disease Patients
CLEVELAND, OH, UNITED STATES, September 23, 2025 /EINPresswire.com/ -- The Pompe Alliance will host a virtual Town Hall on October 23, 2025 at 5pm EST to address how the current federal budget may affect patients living with rare diseases, including Pompe disease.
The event will bring together patients, caregivers, advocates, and policy leaders for a timely discussion on healthcare access, equity, and the unique challenges faced by the rare disease community.
Featured Panelists:
- Paul Howard, PhD: Executive Director, Public Policy and Corporate Affairs at Amicus Therapeutics
- Baillie McGowan, MPH: Director of Policy Research at EveryLife Foundation for Rare Diseases
- John Brad Deane: Constituent Service Liaison Rep. Shontel Brown (OH-11)
- Paloma Juarez: Pompe patient caregiver
βThis Town Hall is an opportunity to elevate the voices of patients and families who are too often overlooked in policy discussions,β said Heather Shorten, Executive Director of the Pompe Alliance. βWe want to ensure that rare disease patients are not left behind in critical budget decisions.β
The event is free and open to the public.
π
Date/Time: October 23, 2025, at 5pm EST
π Location: Virtual (Zoom)
π Registration: https://us02web.zoom.us/meeting/register/tgMcMC8aTLOV4ri0hz45LA
About Pompe Alliance
The Pompe Alliance is a patient-led organization dedicated to supporting individuals and families affected by Pompe disease. Through education, advocacy, and community-building, the Alliance works to improve quality of life and ensure that the voices of patients are heard in healthcare and policy decisions.
Heather Shorten
Pompe Alliance
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
